Skip to content

Anthony Lozama

9 papers in the library · 93 citations · publishing 2006-2012

Papers

Sort Most recent Most cited

Semisynthetic neoclerodanes as kappa opioid receptor probes.

Bioorganic & Medicinal Chemistry May 1, 2012 Kimberly M Lovell, Tamara Vasiljevik, Juan J Araya et al. 35 citations

Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as...

Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.

Journal of Natural Products April 25, 2011 Anthony Lozama, Christopher W Cunningham, Michael J Caspers et al. 40 citations

As part of our continuing efforts toward more fully understanding the structure-activity relationships of the neoclerodane diterpene salvinorin A, we report the synthesis and biological characterization of unique cycloadducts through [4+2] Diels-Alder cycloaddition. Microwave-assisted methods were developed and successfully employed, aiding in functionalizing the chemically sensitive salvinorin...

DOI: 10.1021/np1007872 (opens in new tab) Full text (opens in new tab) Salvinorin a Natural compounds Furan-containing natural products Phytochemistry +12

Synthesis of neoclerodane diterpenes and their pharmacological effects.

Topics in current chemistry 2011 Kimberly M Lovell, Katherine M Prevatt-Smith, Anthony Lozama et al. 17 citations

Salvinorin A is a neoclerodane diterpene that has been shown to be an agonist at kappa opioid receptors. Its unique structure makes it an attractive target for synthetic organic chemists due to its seven chiral centers and diterpene scaffold. This molecule is also interesting to pharmacologists because it is a non-serotonergic hallucinogen, and the first opioid ligand discovered that lacks a...

DOI: 10.1007/128_2010_82 (opens in new tab) Full text (opens in new tab) Salvinorin a Chemical synthesis Drug discovery Opioid ligands +1

Preparation of neoclerodane diterpenes as probes for the opioid receptor system

July 1, 2010 Anthony Lozama, Thomas E Prisinzano, David F. Wiemer et al. 1 citation

While there are a variety of therapeutics that interact with the opioid receptor system, they are not without side effects; including constipation, dysphoria and respiratory depression. A better understanding of the opioid receptor system may yield therapeutic agents with a limited side effect profile. The neoclerodane diterpene, salvinorin A, appears to interact at opioid receptors through a...

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.

Organic & Biomolecular Chemistry September 21, 2009 Denise S Simpson, Kimberly M Lovell, Anthony Lozama et al.

Further synthetic modification of the furan ring of salvinorin A (1), the major active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. A computational study has predicted 1 to be a reproductive toxicant in mammals and is suggestive that use of 1 may be associated with adverse effects. We report in this study that...

Chemical methods for the synthesis and modification of neoclerodane diterpenes.

Bioorganic & Medicinal Chemistry Letters September 15, 2009 Anthony Lozama, Thomas E Prisinzano

Diterpenes are a structural class of molecules that are derived from four isoprene subunits and are widespread throughout nature. A number of neoclerodane diterpenes have been found to have biological activity but a limited number of chemical investigations have been conducted. Recently, the neoclerodane diterpene, salvinorin A (12) has been investigated due to its unique pharmacological...

Herkinorin analogues with differential beta-arrestin-2 interactions.

Journal of Medicinal Chemistry April 24, 2008 Kevin Tidgewell, Chad E Groer, Wayne W Harding et al.

Salvinorin A is a psychoactive natural product that has been found to be a potent and selective kappa opioid receptor agonist in vitro and in vivo. The activity of salvinorin A is unusual compared to other opioids such as morphine in that it mediates potent kappa opioid receptor signaling yet leads to less receptor downregulation than observed with other kappa agonists. Our initial chemical...

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.

Journal of Medicinal Chemistry July 26, 2007 Denise S Simpson, Peter L Katavic, Anthony Lozama et al.

Further modification of salvinorin A (1a), the major active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study that oxadiazole 11a and salvidivin A (12a), a photooxygenation product of 1a, have been identified as the first neoclerodane diterpenes with kappa antagonist activity. This...

Synthesis of salvinorin A analogues as opioid receptor probes.

Journal of Natural Products June 2006 Kevin Tidgewell, Wayne W Harding, Anthony Lozama et al.

Several neoclerodanes, such as salvinorin A (1) and herkinorin (3), have recently been shown to possess opioid receptor activity in vitro and in vivo. To explore the structure-affinity relationships of this interesting class of compounds, we have synthesized a series of analogues from 1 isolated from Salvia divinorum. Here, we report the semisynthesis of neoclerodane diterpenes and their...